Alembic gets USFDA nod for generic skin treatment cream

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US LLC

PTIUpdated: Friday, December 09, 2022, 01:52 PM IST
article-image
Image credit: Wikipedia (Representative)

Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market Desonide Cream used in treating skin conditions with inflammation and itching in the American market.

The company said it has received the final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Desonide Cream, 0.05 per cent.

Aleor Dermaceuticals (Aleor), which was merged with Alembic, filed the ANDA, according to a statement from the drug company.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US LLC.

Desonide Cream, 0.05 per cent, is a low-potency corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

According to IQVIA, Desonide Cream, 0.05 per cent, has an estimated market size of USD 12 million for twelve months ending September 2022.

Alembic said it has now received a cumulative total of 178 ANDA approvals (155 final approvals and 23 tentative approvals) from the USFDA.

(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

MRF Limited declares second interim dividend of Rs 3 per equity share

MRF Limited declares second interim dividend of Rs 3 per equity share

HDFC Life issues 5,38,000 shares as stock options

HDFC Life issues 5,38,000 shares as stock options

Sapphire Foods offers 63,286 shares to employees as stock options

Sapphire Foods offers 63,286 shares to employees as stock options

Earnings 2023 LIVE: MRF income hits Rs 5,604.90 cr, net profit jumps to Rs 169 cr; Sapphire Foods...

Earnings 2023 LIVE: MRF income hits Rs 5,604.90 cr, net profit jumps to Rs 169 cr; Sapphire Foods...

Amid mass layoffs online petition to extend grace period for H-1B visa holders to 12 months launched

Amid mass layoffs online petition to extend grace period for H-1B visa holders to 12 months launched